Navigation Links
Benaroya Research Institute announces $4.4 million grant for type 1 diabetes
Date:2/14/2013

(Seattle, Feb.14, 2013) In a major effort to advance discoveries in type 1 diabetes research, the Benaroya Research Institute at Virginia Mason (BRI) established the T1D Exchange Biobank Operations Center with a $4.4 million grant from The Leona M. and Harry B. Helmsley Charitable Trust. The T1D Exchange Biobank Operations Center led by Carla Greenbaum, MD, Director of the Diabetes Research Program at BRI, will coordinate clinical study proposals and sample requests including protocol design, sample procurement and distribution.

Dr. Greenbaum serves on the Joint Steering Committee for the T1D Exchange which offers a comprehensive view of type 1 diabetes including clinical and academic research, real-world data, clinically-annotated biosamples, and patient insights. The T1D Exchange consists of a Clinic Network with access to more than 100,000 patients, a Clinic Registry with over 26,000 well-characterized patients, the online community Glu, and the Biorepository whose goal it is to distribute, share and exchange meaningful data and biosamples to drive collaboration and disseminate knowledge across the type 1 diabetes (T1D) community.

"We are thrilled to see the establishment of the T1D Exchange Biobank Operations Center as a key factor in advancing the mission of T1D Exchange to speed better treatments, therapies and research. Giving biological samples is one way people touched by type 1 diabetes are empowered to contribute to improved outcomes on the path to a cure. We have a strong, productive working relationship with Dr. Carla Greenbaum and her team at the Benaroya Research Institute and are eager to see this collaboration yield data that will be impactful to the type 1 diabetes community," shared Dana Ball, CEO and Cofounder of the T1D Exchange.

BRI was selected to receive this grant to establish the T1D Exchange Biobank Operations Center by the Helmsley Charitable Trust because of the organization's reputation in autoimmune diseases research with a focus in type 1 diabetes and biobanking. Under the direction of Dr. Greenbaum, BRI has created one of the world's most robust biobanks for the study of autoimmune disorders dating back to the year 2000. BRI actively maintains biobanks for eleven different autoimmune diseases. BRI also maintains a registry of healthy people for comparison purposes.

"BRI has a long track record of developing and maintaining biobanks which have led directly to the advancement of understanding autoimmune diseases, including type 1 diabetes. We are excited to be in on the ground floor of an initiative that will have enormous impact on the type 1 diabetes community by helping to facilitate research with a large numbers of participants. This work will accelerate our understanding, hopefully leading to a cure for this disease," notes Dr. Greenbaum.

"We are pleased to support this important initiative, which is in keeping with our strategy of filling gaps and creating tools that help the entire T1D community," said David Panzirer, a Trustee of the Helmsley Charitable Trust.


'/>"/>
Contact: Kay Branz
kbranz@benaroyaresearch.org
206-342-6503
Immune Tolerance Network
Source:Eurekalert

Related medicine news :

1. Plasticizers Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
2. UNC researchers discover gene that suppresses herpesviruses
3. Researchers discover biological diversity in triple-negative breast cancer
4. Additional noteworthy research to be presented at the 2013 Genitourinary Cancers Symposium
5. Lifespan research program earns national recognition
6. MIND Institute researchers receive $1 million grant to study cognitive training in fragile X
7. Refinery Catalyst Market - New Industry Research Report is Now Available for Pre Order at Transparency Market Research
8. Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors
9. Breast Cancer Research Needs More Focus on Environment: Report
10. UCIs Gavin Herbert Eye Institute receives $3 million for retinal degeneration research
11. Effective treatment for late infantile batten disease developed by MU, BioMarin researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: